UY27410A1 - Formas novedosas crudas cristalinas - Google Patents

Formas novedosas crudas cristalinas

Info

Publication number
UY27410A1
UY27410A1 UY27410A UY27410A UY27410A1 UY 27410 A1 UY27410 A1 UY 27410A1 UY 27410 A UY27410 A UY 27410A UY 27410 A UY27410 A UY 27410A UY 27410 A1 UY27410 A1 UY 27410A1
Authority
UY
Uruguay
Prior art keywords
new crystal
crystal crude
crude forms
forms
crystalline forms
Prior art date
Application number
UY27410A
Other languages
English (en)
Inventor
F Bonifacio
F Campana
Gianluca De Iasi
A Leonardi
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11448245&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY27410(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of UY27410A1 publication Critical patent/UY27410A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Se describen formas cristalinas novedosas del clorhidrato de lercanidipina, estables, no higroscópicas, el procedimiento de preparación de las mismas y composiciones farmacéuticas que contienen las mencionadas formas cristalinas novedosas.
UY27410A 2001-08-06 2002-08-06 Formas novedosas crudas cristalinas UY27410A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001726A ITMI20011726A1 (it) 2001-08-06 2001-08-06 Forme polimorfe della lercanidipina cloridrato

Publications (1)

Publication Number Publication Date
UY27410A1 true UY27410A1 (es) 2003-03-31

Family

ID=11448245

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27410A UY27410A1 (es) 2001-08-06 2002-08-06 Formas novedosas crudas cristalinas

Country Status (36)

Country Link
EP (4) EP1600441B1 (es)
JP (1) JP2005504045A (es)
KR (3) KR100626819B1 (es)
CN (2) CN101475524B (es)
AP (1) AP1766A (es)
AR (1) AR037139A1 (es)
AT (2) ATE307114T1 (es)
AU (1) AU2002327924C1 (es)
BR (1) BR0211739A (es)
CY (2) CY1109711T1 (es)
DE (2) DE60234961D1 (es)
DK (3) DK2157083T3 (es)
EA (1) EA005673B1 (es)
EC (1) ECSP044973A (es)
ES (3) ES2212759T3 (es)
HK (3) HK1067123A1 (es)
HR (1) HRP20040156B1 (es)
HU (1) HU229563B1 (es)
IL (3) IL153917A (es)
IT (1) ITMI20011726A1 (es)
MA (1) MA27133A1 (es)
ME (2) ME01525B (es)
MX (1) MXPA04001069A (es)
NO (2) NO325541B1 (es)
NZ (2) NZ531558A (es)
OA (1) OA12648A (es)
PE (1) PE20030328A1 (es)
PL (1) PL216066B1 (es)
PT (2) PT1600441E (es)
RS (1) RS52161B (es)
SI (3) SI1432683T1 (es)
TN (1) TNSN04024A1 (es)
UA (1) UA82988C2 (es)
UY (1) UY27410A1 (es)
WO (1) WO2003014084A1 (es)
ZA (1) ZA200401806B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
AR043395A1 (es) * 2003-02-28 2005-07-27 Recordati Ireland Ltd Terapia de combinacion para la hipertension utilizando lercanidipina y un bloqueante de los receptores de angiotensina ii
DE04801160T1 (de) * 2003-12-01 2007-08-09 Lifecycle Pharma A/S Pharmazeutische zusammensetzungen mit lercanidipin
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
US8097729B2 (en) 2005-09-16 2012-01-17 Glenmark Generics Ltd. Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
KR100821165B1 (ko) * 2006-03-10 2008-04-14 동우신테크 주식회사 레르카니디핀 염산염의 제조 방법
US20110040097A1 (en) * 2006-12-29 2011-02-17 Dongwoo Syntech Co., Ltd Process for preparing lercanidipine hydrochloride
EP2121575A2 (en) * 2007-03-05 2009-11-25 Actavis Group PTC EHF Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
EP2585051B2 (en) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
EP2444394A1 (en) 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI
WO2012085249A2 (en) 2010-12-24 2012-06-28 Krka, D.D., Novo Mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts
EP2700632A4 (en) * 2011-04-18 2014-09-03 Hefei Beini Medical Technology Company Ltd METHOD FOR CLEANING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND PRODUCING NANOPARTICLES THEREFOR
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102531999B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 无定形盐酸乐卡地平及其制备方法
CN102584682A (zh) * 2011-12-31 2012-07-18 苏州二叶制药有限公司 盐酸乐卡地平的制备方法
CN103497075B (zh) * 2013-09-25 2016-03-23 山西北化关铝化工有限公司 水悬浮延期药造型粉
CN109232389B (zh) * 2018-05-15 2021-10-08 迪嘉药业集团有限公司 一种小粒度硝苯地平的结晶制备方法
CN115353485B (zh) * 2022-07-26 2024-04-19 山西双雁药业有限公司 从硝苯地平母液中回收硝苯地平的方法及应用
CN115671066A (zh) * 2022-11-21 2023-02-03 安徽宏业药业有限公司 一种盐酸乐卡地平缓释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US596139A (en) * 1897-12-28 Process of generating acetylene gas
GB8403866D0 (en) 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
IT1275532B (it) * 1995-07-14 1997-08-07 Recordati Chem Pharm Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
US5696139A (en) 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
IT1274480B (it) * 1995-05-12 1997-07-17 Recordati Chem Pharm Procedimento migliorato per la preparazione della lercanidipina cloridrato
US5912351A (en) 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
WO2001060806A2 (en) 2000-02-16 2001-08-23 Neurogen Corporation Substituted arylpyrazines
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US20040198789A1 (en) 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations

Also Published As

Publication number Publication date
DK1432683T3 (da) 2006-03-06
UA82988C2 (uk) 2008-06-10
PL369522A1 (en) 2005-05-02
NO325541B1 (no) 2008-06-16
TNSN04024A1 (en) 2006-06-01
EP1432683B9 (en) 2006-01-18
HK1086263A1 (en) 2006-09-15
IL164648A0 (en) 2005-12-18
MXPA04001069A (es) 2005-02-17
CN100448847C (zh) 2009-01-07
EP2157083A3 (en) 2010-03-24
ECSP044973A (es) 2004-06-28
AP1766A (en) 2007-08-10
ATE307114T1 (de) 2005-11-15
ME01525B (me) 2011-02-10
DE60206787D1 (de) 2006-03-02
EP1432683B1 (en) 2005-10-19
EP1600441A3 (en) 2005-12-07
ATE453624T1 (de) 2010-01-15
CN101475524B (zh) 2012-08-29
HU229563B1 (en) 2014-02-28
CN1538957A (zh) 2004-10-20
AP2004002989A0 (en) 2004-03-31
CN101475524A (zh) 2009-07-08
CY1109711T1 (el) 2014-08-13
ES2555213T3 (es) 2015-12-29
MA27133A1 (fr) 2005-01-03
DK1600441T3 (da) 2010-02-08
NO20082330L (no) 2004-03-24
IL153917A (en) 2005-11-20
HRP20040156B1 (en) 2012-03-31
EP1600441A2 (en) 2005-11-30
EP2157083B1 (en) 2015-09-30
IL164648A (en) 2007-02-11
KR20050043992A (ko) 2005-05-11
SI1432683T1 (sl) 2006-04-30
WO2003014084A1 (en) 2003-02-20
HK1140487A1 (en) 2010-10-15
IL153917A0 (en) 2003-07-31
NO335651B1 (no) 2015-01-19
PT2157083E (pt) 2016-01-22
EP2036890A1 (en) 2009-03-18
EA005673B1 (ru) 2005-04-28
PT1600441E (pt) 2010-01-20
JP2005504045A (ja) 2005-02-10
NZ541341A (en) 2007-02-23
DK2157083T3 (en) 2015-11-02
SI1600441T1 (sl) 2010-02-26
DE60206787T2 (de) 2006-07-13
KR100667687B1 (ko) 2007-01-12
NZ531558A (en) 2005-12-23
BR0211739A (pt) 2004-09-28
EP1432683A1 (en) 2004-06-30
OA12648A (en) 2006-06-16
ITMI20011726A0 (it) 2001-08-06
NO20040266L (no) 2004-03-24
HUP0401163A3 (en) 2009-04-28
ITMI20011726A1 (it) 2003-02-06
MEP2908A (en) 2010-10-10
EP1600441B1 (en) 2009-12-30
ES2212759T1 (es) 2004-08-01
RS52161B (en) 2012-08-31
AU2002327924B2 (en) 2008-04-24
DE60234961D1 (de) 2010-02-11
CY1117051T1 (el) 2017-04-05
ES2212759T3 (es) 2006-04-16
AR037139A1 (es) 2004-10-27
ES2334678T3 (es) 2010-03-15
HUP0401163A2 (hu) 2004-09-28
PL216066B1 (pl) 2014-02-28
KR100626819B1 (ko) 2006-09-20
KR20050111799A (ko) 2005-11-28
EP2157083A2 (en) 2010-02-24
EA200400280A1 (ru) 2004-08-26
KR20040030903A (ko) 2004-04-09
PE20030328A1 (es) 2003-05-09
SI2157083T1 (sl) 2016-01-29
ZA200401806B (en) 2005-06-29
AU2002327924C1 (en) 2009-12-10
HRP20040156A2 (en) 2004-08-31
HK1067123A1 (en) 2005-04-01
RS11304A (en) 2007-02-05

Similar Documents

Publication Publication Date Title
UY27410A1 (es) Formas novedosas crudas cristalinas
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
CY1117639T1 (el) Φαρμακευτικες συνθεσεις βασιζομενες επι κρυσταλλικης μορφης i της 5-αζακυτιδινης
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
SE0302811D0 (sv) Novel compounds
SE0200920D0 (sv) Novel compounds
NO20040680D0 (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
BR122019010008B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
BRPI0611350B8 (pt) formulação, seus usos e seu processo de fabricação,e artigo de fabricação
CU23616B7 (es) Forma cristalina gamma del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
CU23615B7 (es) Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
SE9904652D0 (sv) Novel Compounds
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
BR0213931A (pt) Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as
SE0401762D0 (sv) Novel compounds
TW200635917A (en) Novel compounds
BRPI0512986A (pt) novos derivados de hidantoìna
HUP0200580A2 (hu) Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
DK1583756T3 (da) Thiophencarboxamider som inhibitorer af enzymet IKK-2
AR052909A1 (es) Base cristalina del trans-1-((1r,3s)-6-cloro-3-fenilindan-1-il)-3,3-dimetilpiperazina
SE0403086D0 (sv) Compounds
UY28248A1 (es) Compuestos quinicos